Endocrinology
Conference Coverage
Noninjectable modes of insulin delivery coming of age
News
Teprotumumab gets FDA go-ahead for thyroid eye disease
It is the first drug to be approved for treatment of the debilitating, autoimmune condition.
Conference Coverage
Treatment of heart failure with preserved ejection fraction is a work in progress
Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care...
Endocrine Consult
How Motivational Interviewing Helps Patients with Diabetes
Ever wondered how you can help your patients become more effective managers of their diabetes? Here’s your introduction to motivational...
Conference Coverage
Reward, decision-making brain regions altered in teens with obesity
CHICAGO – Degradation in these key areas was associated with higher insulin and leptin levels.
News
Nearly one in five U.S. adolescents have prediabetes
Prediabetes is more common in male adolescents than in female adolescents in the United States.
Conference Coverage
DAPA-HF: Dapagliflozin benefits regardless of age, HF severity
PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.
Conference Coverage
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrhea
PHILADELPHIA – It has a very low adverse event profile and is well tolerated.
Conference Coverage
Findings confirm link between methimazole and risk for acute pancreatitis
CHICAGO – However, there is no evidence of a cumulative dose effect.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –